Renalytix Plc – Depositary Receipt () (NasdaqGM:RNLX) has seen a surge in its one-year price target. Analysts have revised the target price to 5.97 per share, marking a significant 21.81% increase from the previous estimate of 4.90, backdated to January 18, 2024.
This price target is an aggregation of multiple forecasts provided by market analysts, varying from a low of 2.51 to a high of 11.94 per share. The average price target signals a substantial jump of 787.86% from the recent closing price of 0.67 per share.
Understanding Investor Sentiment
Currently, there are 31 funds or institutions holding positions in Renalytix Plc – Depositary Receipt (). This indicates a slight decline of 1 owner, equivalent to 3.12% in the last quarter. The average portfolio weight allocated by all funds to RNLX is 0.04%, demonstrating a decrease of 4.73%. Institutional ownership has experienced a 9.43% growth in the last quarter, reaching 5,368K shares.
The put/call ratio for RNLX stands at 0.01, hinting at an optimistic outlook among investors.
An Insight into Shareholder Activities
Cvi Holdings currently owns 1,144K shares of Renalytix Plc, representing a 1.15% stake in the company. In their previous filing, the firm disclosed ownership of 230K shares, indicating an impressive 79.90% increase. The firm has expanded its RNLX portfolio by 26.83% over the last quarter.
Gilder Gagnon Howe & Co holds 879K shares, equivalent to a 0.88% ownership in the company. However, their previous filing showed ownership of 1,012K shares, reflecting a 15.06% decrease. The firm slashed its RNLX portfolio by 80.88% over the last quarter.
Pinnacle Associates owns 847K shares, representing a 0.85% interest in Renalytix Plc. These figures contrast with their prior ownership of 786K shares, showcasing a 7.16% increase. Notably, the firm scaled down its portfolio allocation in RNLX by 77.60% during the previous quarter.
Pentwater Capital Management possesses 700K shares, translating to a 0.70% ownership stake in the company. Their previous report indicated ownership of 598K shares, indicating a 14.51% rise. Nevertheless, the firm reduced its portfolio allocation in RNLX by 40.56% in the last quarter.
Tejara Capital maintains 400K shares, representing a 0.40% ownership in the company, with no changes reported in the last quarter.
Fintel offers a comprehensive investing research platform for individual investors, traders, financial advisors, and small hedge funds. Our data spans the globe, incorporating fundamentals, analyst reports, ownership data, fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and more. Additionally, our exclusive stock picks leverage advanced, backtested quantitative models for enhanced profitability.
Join the ranks for more insights.
This article was originally published on Fintel.
The expressed views and opinions herein belong to the author and may not necessarily align with those of Nasdaq, Inc.
